This prospective, controlled study was undertaken to determine whether addition of adrenaline or fentanyl to bupivacaine or warming of the injectate had any effect on the incidence of shivering following extradural analgesia in the labouring parturient. Eighty-four patients were sequentially allocated to four groups (control, warm injectate, extradural adrenaline and extraduralfentanyl). The adrenaline group had the highest incidence of shivering, the warm injectate and fentanyl groups the lowest. Extradural fentanyl also seemed promising in reducing shivering in pre-block shiverers. This paper also explores the rapidity of temperature decay of solutions ofbupivacaine in different clinical situations.
PATIENT SELECTION Eighty-four (84), healthy, afebrile, fullterm, ASA I and 11 labouring women who had given prior consent were included in the study. Patients receiving phenothiazines or psychotropic medications or who had previously received narcotics, sedatives or agents recognised as modifiers of body temperature regulation were excluded from participating.
In previous studies, patients who had been shivering prior to insertion of the extradural block were not studied. 1 In the design of this study these 'pre-block shiverers' were deliberately included so as to more closely approximate the clinical situation. METHOD The study protocol, which was approved by the Human Studies and Medical Ethics Committee of the Royal Hospital for Women, consisted of two parts:
a. An in vitro pilot measurement of the temperature decay curves of bupivacaine 0.5% which had been warmed to different temperatures. This was studied for both glass ampoules and glass syringes. b. A clinical, in vitro study in which three putative modifiers of extradural-or pregnancy-associated shivering were studied:
1. Presence of adrenaline in the injectate, 2. Addition of fentanyl to the local anaesthetic (LA) solution, 3 . Warming of injectate.
The study was carried out between June and September 1985. 
Temperature decay curves of warmed LA Solutions
A rapidly-responding ELLAB Instruments TE3 galvanometric thermocouple which was calibrated prior to each set of readings was used to simultaneously measure the baseline temperature of 0.5% bupivacaine and that of the surrounding water bath. Temperatures of the local anaesthetic solutions were then measured every 15 seconds under two sets of conditions: a. when the ampoule was withdrawn from the water bath into an ambient temperature of 21 QC and not dried ( Figure 1 ); b. when the contents of the ampoule were drawn into a 'cold' (21 QC) syringe at room temperature ( Figure 2 ).
The experiment was repeated using a variety of baseline temperatures to produce families of temperature decay curves ( Figures  1 and 2 ).
Clinical study
The 84 parturients were divided into four sequential groups: Group 1 Control Group These 20 patients received an extradural block with 0.5% bupivacaine plain 10 ml (50 mg) at labour ward room temperature (-21 QC). Group 2 Warm Injectate Group These 22 gravidae received extradural 0.5% bupivacaine plain 10 ml (50 mg) which had been warmed in a thermostatically-controlled water-bath to 38.5-39 9 C.
Group 3 Adrenaline Group
This group of 21 parturients received extradural of 0.5% bupivacaine 10 ml (50 mg) with 11200,000 adrenaline at ambient temperature (-21 QC).
Group 4 Fentanyl Group
These 21 patients had an extradural block with 0.5% bupivacaine plain 9 ml (45 mg) + fentanyl 1.0 ml (50 ~g) at labour ward temperature (-21 Q).
All patients were preloaded with 15-20 mVkg lactated Ringer's (Hartmann's) solution infused at labour suite temperature (-21 QC) over 30 minutes. In all cases, the skin was prepped with 0.5% chlorhexidine in 70% alcohol. All patients were placed in the left lateral position and the L2-3 or L3-4 extradural space was identified using loss of resistance to 2-3 ml of air. This was followed by an aspiration test. Test dosing with Pain and anxiety levels ~ analogue scores for pain and anxiety prior to extradural block;
Labour ward ambient temperature; Absence/presence of shivering prior to insertion of the block.
In each group, the 10 ml injection was made through the needle over a 30-second period. In instances where blood was detected in the needle on aspiration, the patient was withdrawn from the study and was subsequently managed according to our anaesthetic department protocol for 'bloody' tap. There was no instance of dural tap.
In the 'warm injectate group' (Group 2), it was of paramount importance that the injectate be withdrawn from the water bath, drawn into the syringe and injected through the needle in under 60 seconds ( Figure 2 ). This meant that the water bath had to be brought into the delivery room, and only after proper placement of the needle was the injectate drawn up into the sterile syringe.
Only when the injection was completed, was a catheter inserted -in a cephalad direction -and the patient rotated into the right lateral position. She was then covered with a sheet and nursed in the lateral position. At 5, 10,20 and 30 minutes after institution of the block the following observations were made:
Block level -sensory levels to pinprick on both sides;
Shivering -absence or presence of shivering by direct observation;
Patient temperature -oral and axillary temperature;
Cardiorespiratory parameters -systolic, mean and diastolic systemic pressures, pulse rate and respiratory rate.
If a patient was still shivering at the end of the 30-minute study period, she was covered with blankets warmed in a blanket-warming Anaesthesia and Intensive Care. Vol. 18 . No. I. February. 1990 cupboard. This was usually successful at diminishing shivering.
RESULTS

Temperature decay curves of warmed injectate
U sing starting temperatures of 44°C, 41.7"C, 38°C and 35.6°C, bupivacaine in ampoules exhibited a rapid, quasi-linear temperature decay at a rate of 0.7-1.0°C/ minute (Figure 1 ). When the bupivacaine was drawn into the glass extradural syringe (at ambient temperature) there was an immediate fall in temperature of 5°C occurring in the first 90 seconds. This was followed by a more gradual linear decay of 0.7-1.0°C/minute ( Figure 2 ).
Clinical study
There were no significant differences in mean age, height, weight, labour suite ambient temperature, gestational age, level of sensory block to pinprick, systemic blood pressure (systolic, mean, diastolic), pain and anxiety analogue scores and baseline mean (oral and axillary) temperatures in th~ four groups.
The total number of patients who shivered, at any time after injection, is reported in Table  2 . There were only six out of 22 (27.3%) patients who shivered in the warm injectate (mean 36.3°C) group as compared to eleven out of 20 (55%) in the 'cold' (mean 22.3°C) control group (Chi 2 P < 0.05). The highest incidence of shivering was seen when 'cold' adrenaline-containing bupivacaine was injected into the extradural space (0.20 < P < 0.30; not significant at P < 0.05 level). In this adrenaline group, sixteen out of 21 (76.2%) patients shivered at some time in the 30 minute observation period. In the fentanyl group, seven out of21 (33.3%) of the patients shivered (significant at 0.02 < P < 0.05). These results are summarised in Figure 3 . The effect of fentanyl and warming of injectate becomes even more interesting when one takes into account those patients who were shivering before establishment of the extradural block. Patients at full-term pregnancy, and especially those in labour, have a reset 'thermostat' so that shivering in these patients, even if they have not received an extradural block, is quite common. In the fentanyl and warm injectate groups, the number of parturients shivering is actually less after insertion of the block. (Figure 4 ). This is best designated by the equation: [(number of patients shivering)-(preblock shiverers)-(largest number of preshiverers)] which eliminates all those who were shivering before the block was inserted and allows us to look at the 'de novo' shiverers. This is summarised in Figure 5 .
It can be seen that, when we eliminate the 'pre-block shiverers', the incidence of shivering is increased (but not to any significant extent) in those who had an adrenaline-containing extradural (Group 3), was significantly less in those who received warmed injectate (Group 2) and was least in those received the fentanyl-containing solution (Group 4). The major contribution of fentanyl seems to have been in eliminating shivering in those who were already shivering prior to insertion of the block.
DISCUSSION
Shivering following extradural analgesia occurs in 20-61 % of parturientl· 7 and 23% of normal, patients without extradural analgesia in labour. 8 Though this shivering-cutaneous vasoactivity syndrome, which is often intense and uncontrollable, has been identified as the single symptom most likely to disrupt the delivery and make the birth experience unacceptable and disconcerting,9 the aetiology remains unclear. In Brownridge's study, most parturients regarded shivering as a trivial symptom but 13% described it as 'very irritating'. I Theories regarding causative and modifying elements in the imbalance of thermogenesis following stress, epidural analgesia, labour and surgical trauma abound. It has been suggested that injection of 'cold' epidural solutions may produce differential inhibition of spinal cord afferent thermoreceptor fibres or a direct effect on temperature sensors in the extradural space or the spinal cord. IO • 11 Peripheral vasodilation and increased skin blood flow may be responsible for elevated shell temperature and increased heat loss in the area of distribution of the block. 12 ,13 Whatever the mechanism, it seems likely that extrathalamic thermosensitive structures are partly responsible for body temperature maintenance. I ,II.14 This study supports the concept that local warming of the thermoreceptors in the spinal cord helps reduce the incidence of shivering.
Factors contributing to depressed core temperatures l2 ,I3,I5 include rapid intravenous infusion of cold fluids, 15 injection of cold local anaesthetic into the epidural space 2 and low ambient temperatures. 16 If'warm' sensation is blocked before 'cold' sensation, the 'cold' input to the CNS I7 may result in an inappropriate thermal response to false information received from the modified peripheral thermal cues. 18 Other contributors to the phenomenon include increased CNS Anaesthesia and Intensive Care. Vol. 18 . No. I. February. 1990 irritability due to absorbed local anaesthetic,2,19,2o transfer of pyrogenic substances across the placenta, absorption of adrenaline 21 and release of fever mediators such as interleukin-l. 22 This investigation attempts to eliminate, as far as possible, other postulated causes of shivering and to assess the three variables under study: injectate temperature, extradural adrenaline and extradural fentanyl.
Several solutions to the problem of shivering following injection of fluids into the extradural space have been proposed, and include injection of warmed extradural solutions,1I use of radiant heat,23 warm blankets, extradural pethidine I and warming of intravenous fluid. 15 . 24 While some of these methods are considered ineffective (eg. warming blankets 23 ), others may be hazardous (eg. injection of extradural solutions warmed in non-thermostatically controlled operating room warming cabinets 25 ) . From this study it would seem that warming the injectate can, indeed, reduce the incidence of shivering. Interpretation of the literature is complicated further by the knowledge that mothers in labour respond differently in their thermoregulatory responses to non-pregnant controls. 25 Indeed, there is a 22-23% incidence' of shivering in labour in parturients not offered extradural analgesia. 8 ,25 The rapid decay of the temperature of warmed bupivacaine solutions, especially when the solution is drawn into syringes at ambient temperature, reinforces our belief that studies which look at incidence of shivering following warming or cooling of injectate need to be scrutinised carefully with regard to experimental design and technique. Such variables as total time of injection, warming of equipment (particularly the glass syringe) and direct injection through the needle as opposed to use of an extradural catheter can alter the temperature of injectate delivered to the extradural space by over 10°C. This may explain the discrepancy in results of researchers working in this area. 2 ,II,14 While it seems increasingly certain that alteration in the temperature of the extradural space or spinal cord can be responsible for increased shivering, some studies aim to accentuate this effect by injecting very cold (4°C) solutions into the extradural space. While this approach is useful in testing the hypothesis, it has few applications in clinical practice. Even when we are armed with the knowledge that warm injectate can reduce shivering, even warming the solutions to 'body' temperature, as in our study, introduces several practical difficulties in such areas as maintenance of sterile technique and avoidance of injection of unduly hot solutions extradurally.
While the association between bupivacaine concentration 1 or volume 14 and shivering had been tested previously, our clinical impression that parturients receiving extradural adrenaline-containing solutions shivered more often had never received attention. In this study, we were unable to show a significant relationship between adrenaline-containing solutions and plain solutions.
Though a previous study by Brownridge 1 looked at intramuscular and extradural pethidine rather than extradural fentanyl, our findings are very similar. Fentanyl is very effective in reducing shivering in those already shivering but only marginally reduces the incidence of 'de novo' shivering. We conclude that, in those patients already shivering at the time of insertion of the block, it is valid to include an extradural dose of fentanyl of -1.0 Ilglkg. Our study also lends support to our clinical impression that shivering occurring following insertion of the block may be abolished or ameliorated by injecting the fentanyl in about 4 to 5 ml of normal saline. CONCLUSION The incidence of shivering decreased markedly in patients receiving warm injectate or fentanyl-containing local anaesthetic. Fentanyl was particularly efficacious in reducing shivering in those who were already suffering from this symptom prior to insertion of the extradural block. The increased incidence of shivering in the adrenaline recipients did not reach statistical significance.
